


































In mammals, aging is a complex phenomenon likely to 
result from a myriad of molecular changes. Studying 
mammalian aging experimentally represents an obvious 
challenge that has hampered our understanding of the 
molecular mechanisms underlying this process. In 
culture, cells have a limited proliferative lifespan in 
which they undergo an irreversible cell cycle arrest 
known as replicative senescence [1]. Cellular senescence 
corresponds to an irreversible exit from the cell cycle and 
can be triggered in primary cells by different stimuli, 
including expression of activated oncogenes (oncogene-
induced senescence), or serial passaging (replicative 
senescence). Specifically, cellular senescence is believed 
to occur when cellular growth is promoted while cell 
cycle progression is inhibited, as observed for example 
upon strong mitogenic stimuli [2, 3]. Irrespective of the 
stimulus used to drive senescence, senescent cells beco-
me flat and enlarged, and are positive for β-galactosidase 
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activity in acidic conditions [4]. Senescence is believed 
to reflect the aging process at a cellular level, and 
therefore represent an ideal model system to study the 
molecular basis of aging. While there has been some 
question as to whether cellular senescence contributes 
to organismal aging, it is believed that senescence can 
lead to the reduction of the regenerative potential of the 
stem cell pool. Additionally, accumulation of senescent 
cells in tissues could impair tissue function [5]. 
Importantly, recent studies using skin biopsies from 
mammals have shown that senescent cells accumulate, 
in vivo, during aging and can end up representing more 
than 15% of total cells in aged animals [6]. This study 
suggests that cellular senescence is a hallmark of 
organismal aging.  
 
Importantly, chromatin modifications have been shown 
to play a role in the determination of the senescent 
phenotype. In eukaryotic cells, DNA is tightly associa-
ted with histones as well as non-histones proteins to 
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assembled as octamers composed of two copies of each 
core histone, H2A, H2B, H3 and H4 to form the 
nucleosome. Through post-translational modifications 
and protein recruitment, the nucleosome is an essential 
component of dynamic chromatin regulation. Histones 
are subjected to specific modifications including 
acetylation, methylation, phosphorylation, ubiquitylat-
ion, ADP-ribosylation and sumoylation, while DNA 
itself can be methylated [7, 8]. These specific 
modifications result in higher order chromatin structure 
and regulate DNA accessibility. Importantly, the 
combination of different modifications results in 
specific transcriptional or structural outcomes, 
underlining the existence of a ”histone code” [9, 10]. 
Such a code tremendously enhances the degree of 
information coded solely by the DNA molecule. 
Therefore chromatin modifications impact all biological 
processes related to DNA, including gene expression 
and genomic stability, both of which are at the nexus of 
the senescent phenotype. Here we discuss the evidence 
suggesting that chromatin modifications can be the 
driving force behind the senescent phenotype and their 
implications in organismal aging. 
 
Age related DNA methylation changes 
 
Early experiments in mammalian cells have 
demonstrated the occurrence of a global decline in DNA 
methylation in cultured primary fibroblasts from mice, 
hamsters, and humans compared to their immortalized 
counterparts. These observations suggested for the first 
time that replicative senescence may correlate with 
changes in chromatin structure [11]. Importantly, these 
results have also been confirmed in vivo [12], as the 5-
methyldeoxycytidine content in DNA isolated from 
mouse livers, brains, and small intestinal mucosa 
significantly decreased as the animals age. The overall 
decline of methylation results mostly from the loss of 
DNA methylation at repetitive regions. Repetitive 
sequences, including satellite repeats at pericentric and 
centromeric loci, and interspersed repeat sequences, 
represent about 45% of the mouse genome [13] and are 
normally highly methylated. It is widely accepted that 
DNA methylation correlates in most cases with the 
generation of a repressive chromatin structure, thus 
preventing potential deleterious recombination within 
repetitive DNA sequences. Interestingly, these 
deleterious recombinations accumulate with age, 
leading to increased incidence of disease including 
cancer [14], suggesting that the progressive loss of 
DNA methylation at repeat sequences may account, at 
least in part, for the accumulation of genomic aberration 
in aging organisms. In addition, since DNA methylation 
is normally associated with gene repression, it is 
conceivable that hypomethylation of these regions 
results in gene re-expression at these loci. 
 
Despite a global decrease in total DNA methylation, 
specific sites in the genome become hypermethylated as 
mammals age [15], suggesting that the enzymatic 
activity associated with DNA methylation is not entirely 
impaired during the aging process. This increase in 
DNA methylation occurs mainly at CpG islands, which 
are typically unmethylated in normal tissues. However, 
methylation at discrete CpG islands increases during the 
aging process [15]. Specifically, the locus encoding the 
estrogen receptor gene has been shown to become 
increasingly methylated at CpG islands in human colon 
in an age dependent fashion [16]. Similarly, genes 
encoding ribosomal RNA become progressively 
methylated in rat liver [17]. Finally, multiple tumor 
suppressor or tumor related genes such as APC, E-
cadherin, GSTP1, and p16
INK4A have shown different 
levels of methylation in an age and tissue specific 
manner [15, 18, 19].  
 
While the significance of these changes remains 
unclear, these observations, pointing to the differential 
modulation of DNA methylation at gene-specific loci 
with age, are at first glance in agreement with the 
“redistribution of chromatin modifiers” (or RCM) 
hypothesis [20]. According to the RCM hypothesis in 
aging, chromatin modifiers leave their normal target 
loci as the cell ages, and are relocalized to other sites, 
thus altering the chromatin structure in two ways. 
However, the substrate specificity of methyl-
transferases makes this unlikely in the case of DNA 
methylation. Various enzymes account for the 
methylation events that occur on genomic DNA in 
mammals. Dnmt1 is responsible for methylating newly 
replicated DNA and, accordingly, uses hemimethylated 
DNA as a substrate; it is therefore responsible for 
maintaining methylation patterns [21]. In contrast to 
Dnmt1, the related Dnmt3a and Dnmt3b enzymes 
contribute to de novo methylation, in that they can 
methylate previously unmethylated DNA [22]. 
Enzymatic assays have revealed a decrease in 
maintenance methylation concomitant to an increase in 
de novo methylation in senescent human fibroblasts 
compared to their early passage counterparts [23]. 
Accordingly, the amount of transcripts corresponding to 
Dnmt1 decrease significantly as fibroblasts senesce, 
while Dnmt3b transcription is up-regulated, suggesting 
the loss of methylation results at least in part from 
changes in Dnmts transcriptional regulation [24]. 
Collectively, these observations suggest that during the 
aging process, a change in the balance between de novo 
methyl-transferases and maintenance methyl-
transferases is likely to contribute to the changes 
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in DNA methylation directly contribute to cellular aging 
or represent a mere consequence of this phenotype 
remains an unresolved issue.  
 
Histone modifications, histone modifiers, and 
senescence 
 
As presented above, histones are modified at many 
residues within the tails or even the globular domains, 
where different covalent modifications can be found 
[10, 25]. Specific histone modifications have yet to be 
fully studied and understood in organismal aging. 
Deciphering the contribution of specific histone 
modifiers to the aging phenotype is impaired by the 
usually pleiotropic effects of these enzymes, whose 
inactivation leads in many cases to cell lethality.  
 
In spite of these impediments, specific histone 
modifications have been linked to the aging process. 
For example, trimethylation of histone H4 at lysine 20 
(H4K20me3), a hallmark of constitutive hetero-
chromatin, increases in rats livers with age, and is found 
upregulated in a cellular model of progeria [26, 27]. 
Since genetic inactivation of Suv4-20, a family of 
enzymes responsible for this modification, results in 
proliferation defects due to increased sensitivity to 
DNA damage, the specific function of these enzymes in 
cellular senescence remains unclear [28]. In addition, 
the modulation of Suv4-20 methyl-transferase activity 
or expression level in young versus old cells or tissues 
has yet to be investigated. By contrast, a direct and 
well-established function for a histone modifier in 
senescence is that of the histone methyl-transferase 
EZH2. As reviewed in [29], the INK4A locus is a major 
player in the induction of senescence in mammalian 
cells. Upon replicative or oncogenic stress, the products 
of this locus, the p19
ARF and p16
INK4A proteins, 
accumulate, leading to growth arrest. Recent studies 
have implicated an EZH2-containing complex (known 
as PRC2) in the transcriptional repression of the INK4A 
locus in proliferating cells. Upon signals triggering 
senescence, EZH2 levels decrease, concomitant with the 
loss of H3K27me3 mark at the INK4A locus [30]. 
While these observations definitely implicate a histone 
methyl-transferase on the induction of a senescence 
transcriptional program, whether active demethylation 
on H3K27 is also involved in this process remains 
unclear [31]. Finally, the histone demethylases KDM2a 
and KDM2b, which target methylated H3K36, prevent 
senescence by modulating the p53 and Rb pathway [32, 
33]. Specifically, overexpression and loss-of-function 
experiments have shown that this function is 
accomplished through their ability to demethylate 
H3K36me histones at the p15
INK4B locus, leading to its 
repression. Together, these data demonstrate that 
histone modifiers are able to contribute in a gene-
specific manner to the induction or prevention of 
cellular senescence. By contrast, the contribution of 
chromatin modifiers to cellular senescence and aging as 
global regulators of chromatin structure remains elusive 
and awaits genome-wide approaches to definitively 
ascertain these functions. 
 
Similar to what was reported for DNA methylation, the 
total levels of histone acetylation are likely to change as 
the organism ages. Consistent with this observation, the 
levels of the histone deacetylase HDAC-1 decrease 
upon serial passaging of primary human fibroblasts 
[34]. Importantly, treatment of primary human 
fibroblasts with the HDAC inhibitors Trichostatin A 
(TSA) or sodium butyrate induce a senescence-like 
state, suggesting that modulation of histone acetylation 
through class I and II HDACs is an essential step in the 
establishment of senescence [35]. Whether this effect 
results from global changes in histone acetylation or 
from the transcriptional activation of discrete loci 
remains unknown. Seemingly contradictory, the recent 
observation that HDAC1 overexpression in melanoma 
cells is sufficient to induce an irreversible senescence 
program demonstrates that the function of class I 
HDACs in senescence is likely to be more complex than 
initially anticipated [36]. The precise contribution of 
HDAC1 and other class I and II HDACs to the 
establishment and maintenance of the senescent state 
and organismal aging will undoubtedly become more 
clear in the near future as genome wide approaches, 
including promoter location analysis, allow the 
delineation of HDACs targets upon pro-senescence 
signals.  
 
The complex case of sirtuins 
 
The members of the evolutionary conserved Sirtuin 
family of proteins are nicotinamide adenine 
dinucleotide (NAD)-dependent proteins with histone 
deacetylase activity, whose founding member is the 
yeast Sir2 protein. In yeast, worms and flies, extra 
copies of sirtuins extend replicative lifespan, and the 
deacetylase enzymatic activity of sirtuins is required for 
this function [37-40]. Additionally, Resveratrol, a 
potent inducer of sirtuins enymatic activity, extends life 
span in these species, in a sirtuin-dependent manner 
[41]. The correlation between sirtuins and aging in 
metazoans has led to an interest in the mammalian 
homologs of Sir2, the SIRT proteins. The mammalian 
SIRT family consists of seven members, SIRT1-7. 
SIRT1, however, is reported to be the most similar to 
yeast Sir2. The contribution of SirT1 to senescence and 
aging in mammals is complex, and may involve non-
   
www.impactaging.com                    184                              AGING, February 2009, Vol.1 No.2chromatin substrates. For instance, SIRT1 was shown to 
deacetylate p53 in vivo, leading to p53 inactivation [42-
44]. In addition, loss-of-function experiments in mouse 
fibroblast demonstrated that SIRT1 is required for 
replicative senescence resulting from chronic genotoxic 
stress [42]. In these experiments, SIRT1-/- mouse 
embryonic fibroblasts (MEFs) fail to upregulate p19
ARF 
upon serial passaging in normal culture conditions, 
correlating with their inability to undergo replicative 
senescence. Whether this effect of SIRT1 on p19
ARF 
regulation involves chromatin regulation or involves the 
deacetylation of a non-histone protein is unknown. 
Recently, a direct correlation between SIRT1 regulation 
of chromatin structure and aging has been uncovered in 
mouse embryonic stem cells [45]. Using genome-wide 
location analysis, it was demonstrated that, upon 
genotoxic stress, SIRT1 is delocalized from repeat 
sequences and numerous gene promoters to bind to sites 
of DNA damage, in a process consistent with the afore-
mentioned “RCM” hypothesis (for redistribution of 
chromatin modifiers). Such relocalization may affect 
the aging process in a dual manner: First, it may 
suppress genomic instability by contributing to DNA 
repair upon chronic genotoxic stress that occurs in aging 
organisms. Second, the loss of SIRT1-driven 
transcriptional repression at its natural targets correlates 
with the deregulation of gene expression consistent with 
what is observed in aging tissues [45]. These 
observations strongly suggest that forced expression of 
SIRT1 may represent a strategy to alter aging-related 
chromatin changes in mammals.  
   
Another mammalian sirtuin family member, the SIRT6 
protein, has been involved in aging-related chromatin 
changes in mice. SIRT6 deficient mice display a 
premature aging-phenotype and die rapidly after birth, 
displaying an acute multi-organ degenerative syndrome 
[46]. While SIRT6 has been shown to prevent telomere 
dysfunction in human cells by deacetylating H3K9 at 
telomeric loci (see below), this function is not 
conserved in mouse cells and therefore cannot account 
for the aging-phenotype in SIRT6-/- mice [47]. A recent 
report shed light on a potential molecular mechanism 
for SIRT6-mediated prevention of aging in mice [48]: 
SIRT6 was shown to be tethered by NF-κB target genes 
and to deacetylate H3K9 on these promoters, thus 
attenuating this signaling pathway. Since NF-κB has 
been implicated in the induction of a senescence 
specific program and genetic alteration of NF-κB 
signaling rescues the aging phenotype elicited by SIRT6 
deficiency [48, 49], it is tempting to conclude that 
SIRT6 prevents aging at least partly through the 
modulation of the chromatin structure and transcription 
program driven by this specific signaling pathway. 
Finally, reinforcing the connection between DNA 
damage and cellular senescence, SIRT6 was recently 
shown to deacetylate H3K9 at sites of double strand 
breaks (DSB), and to be required for the mobilization of 
DNA-PK at these sites and the subsequent resolution of 
DSBs [50].  
 
Senescence Associated Heterochromatic Foci and the 
induction of senescence 
 
As presented above, senescence, along with stem cell 
depletion, is one cellular manifestation of organismal 
aging. A direct involvement of chromatin modifications 
in the establishment of the senescent phenotype was 
recently revealed in that senescent cells display 
specialized and discrete subnuclear structures called 
Senescence  Associated  Heterochromatic  Foci (SAHF) 
[51]. SAHF were first described in human primary 
fibroblasts driven to senescence via serial passaging or 
oncogenic stress [52]. Importantly, these hetero-
chromatic foci are not present in quiescent cells. SAHF 
are easily stained in senescent human cells upon 
incubation with 4’-6-Diamidino-2-phenylindole staining 
(DAPI), resulting in the visualization of bright positive 
nuclear foci. These foci are resistant to digestion by 
nucleases, consistent with the dense heterochromatic 
nature of the corresponding genomic loci. Indeed, 
SAHF contain chromatin marks that are reminiscent of 
those found in constitutive heterochromatin, including 
hypoacetylated histones, methylation of lysine 9 of 
histone H3, and Heterochromatin Protein 1 (HP1) [52]. 
However, SAHF also contain specific marks, absent 
from constitutive heterochromatin such as enrichment 
of macroH2A and HMGA proteins and depletion of 
linker histone H1 [53-55]. Consistent with a function in 
the permanent cell cycle exit upon induction of 
senescence, SAHF embed genomic loci encoding pro-
proliferative proteins into heterochromatin structures, 
thus preventing their accessibility by the transcription 
machinery [52]. In addition, it appears that each 
chromosome condenses into one single SAHF, where 
the loci to be repressed are found in the interior or 
immediate periphery of the corresponding focus [55]. 
The molecular events leading to the formation of SAHF 
are still under investigation, but several proteins have 
been demonstrated to contribute to the formation of 
SAHF: They include the histone chaperones HIRA and 
Asf1, HP1γ, HMGA  proteins, and the H3K9me3 
methyl-transferases Suv39h1/h2 [54, 56, 57]. Impor-
tantly, genetic disruption of Suv39h1 in mouse 
lymphocytes promotes tumorigenesis by preventing 
oncogene-induced senescence upon activated Ras 
overexpression [56] This important result suggests that 
the formation of SAHF is essential for senescence to 
occur in vivo. However, it is important to note that 
primary fibroblasts inactivated for Suv39h1 and h2 
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This discrepancy suggests that either the formation of 
SAHF upon replicative or oncogene signal utilize 
different pathways, or that the enzymatic machinery 
required for SAHF formation differs in lymphocytes 
and in fibroblasts. More experiments are needed to 
precisely define the contribution of SAHF to the 
senescent phenotypes. In addition, many questions 
regarding the generation of these specialized loci 
remain, including the identity of the complex required 
for the deacetylation of the loci embedded in SAHF, as 
well as the molecular basis for the targeting and 
coordination of the different chromatin modifying 
activities affecting SAHF formation. Finally, since all 
chromatin modifications identified in SAHF have now 
been shown to be reversible, the irreversible nature of 
senescence is likely to rely on additional molecular 
mechanisms yet to be identified.  
 
Lamins, progeria and the aging phenotype 
Lamins belong to a family of intermediate filaments, 
which are the main structural components of the nuclear 
lamina. They have been shown to play a role in 
chromosome organization and to interact with 
chromatin and DNA through lamin binding proteins 
[59]. Importantly, lamins are mutated in multiple human 
diseases, known as laminopathies. The connection 
between lamins and aging was first suggested through 
the genetic analysis of a progeria syndrome: 
Hutchinson-Gilford progeria syndrome (HGPS) is a rare 
genetic disorder characterized by premature aging. 
Patients are born normal, but develop age-associated 
disorders within a year after birth. Characteristic 
symptoms include hair loss, artheriosclerosis, loss of 
subcutaneous fat, growth retardation, osteoperosis, and 
aged skin [60]. HGPS is caused by a single nucleotide 
substitution in the Lamin A gene resulting in a cryptic 
splice site in exon 11 causing a 150 nucleotide-deletion 
from the 3’ end of the lamin A gene, leading to the 
synthesis of an abnormal protein, LA∆50 [61, 62]. 
Fibroblasts from young HGPS patients have relatively 
normal nuclei and nuclear lamina. However, as these 
cells are passaged in culture, several abnormalities 
become detectable in the nucleus. These include 
lobulation of the nuclear envelope, thickening of the 
nuclear lamina, clustering of nuclear pores, and loss of 
peripheral heterochromatin [59]. The severity of these 
nuclear abnormalities is highly correlated with an 
overall accumulation of the LA∆50 protein upon 
passage in culture [63]. Importantly, ectopic expression 
of LAΔ50 protein in normal cells is sufficient to 
recapitulate the nuclear defects observed in cells derived 
from HGPS patients [63]. Further strengthening the 
connection with cellular aging is the recent observation 
that similar mechanisms and defects occur in healthy 
individuals. Indeed, fibroblasts from older healthy 
individuals (81 to 96 years) express the LA∆50 
transcript at low levels and display nuclear defects 
similar to those from HGPS patients [64].  
At the chromatin level, HGPS fibroblasts exhibit a loss 
of nuclear peripheral heterochromatin, and, in cells 
derived from older HGPS patients, several hetero-
chromatin marks, including mono-methylated H3K9 
and tri-methylated H3K9, are globally almost 
undetectable. As female HGPS fibroblasts are passaged 
in culture, a reduction of H3K27 trimethylation is 
observed on the inactive X chromosome. In fact, loss of 
this mark was detected in early passage cultures before 
any nuclear defects were observed suggesting 
heterochromatin defects precede nuclear defects [27]. 
The loss of the H3K27 tri-methyl mark was also 
correlated with a 9-10 fold decrease in EZH2, the 
enzyme responsible for maintenance of this mark [27]. 
Furthermore, late-passage HGPS cells show an 
upregulation of H4K20 tri-methyl [27], which, as 
presented above, is also observed in livers of older rats 
[26]. Importantly, similar defects in heterochromatin-
ization accumulate, though to a lesser extent, in aging 
wild-type cells. Specifically, skin fibroblasts from 
healthy old individuals (81-96 years) show decreased 
staining for HP1 and H3K9me3 compared to the same 
cells from young individuals (3-11 years) [64].  
The molecular mechanisms linking lamin A to 
heterochromatin remains unclear, but two hypothesis 
are currently being explored. First, the function of 
specific transcription factors could be affected by 
mutations in Lamin A. One candidate is the 
retinoblastoma protein, Rb, which binds directly to 
type-A lamins and whose function is regulated by this 
association [65, 66]. Given the role of Rb in the 
regulation of histone methylation [67], including 
H3K27, H3K9 and H4K20, it is conceivable that 
alteration of Lamin A affects histone methylation 
through impairment of the Rb pathway. A second, non-
exclusive, hypothesis is that defects in Lamin A protein 
induce changes in nuclear localization of specific loci. 
For example, chromosome territories can be displaced 
from the nuclear periphery to the nuclear interior upon 
expression of mutant Lamin A. This would be 
consistent with the recent demonstration that Lamins 
associated microenvironments are organized into 
transcriptionally defined domains [68]. Given the 
connection between nuclear tethering and transcript-
tion/chromatin modifications [69], alterations in nuclear 
envelope structure resulting from Lamin A mutations 
are likely to affect chromatin globally. Although still 
correlative, these studies strongly suggest that loss of 
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drive the premature aging process and may contribute to 
the normal aging process. 
 
Chromatin structure of telomeres and the aging 
phenotype 
 
Telomeres are repetitive DNA elements at the tips of 
chromosomes that protect DNA ends from recom-
bination and degradation [70]. As mammals age, their 
telomeres become shorter during each round DNA 
replication due to the inability of the transcription 
machinery to completely replicate the ends. Eventually, 
human telomeres reach a critically short length that 
activates the DNA damage pathway leading to 
replicative senescence. Telomere attrition is considered 
to be a mechanism for organismal aging in which 
shortened telomeres lead to stem cells depletion and 
eventual loss of tissue regeneration [71].  
 
Telomeres from normal mouse lab strains are much 
longer than those from humans and therefore, do not 
erode enough to induce senescence. However, studies in 
mice have allowed elucidation of the mechanisms 
behind epigenetic regulation of telomeres, which are 
likely to be relevant in other mammalian species. These 
studies demonstrate that telomeres are heterochromatic 
in nature, and that loss of heterochromatic marks may 
regulate telomere length, thus potentially affecting 
cellular aging. Specifically, subtelomeric regions 
comprise methylated DNA, as well as H3K9 and 
H3K20 methylated nucleosomes [72, 73]. Loss of DNA 
methyltransferase activity in mouse embryonic stem 
cells results in decreased methylation at subtelomeric 
regions hence increased telomere recombination [74]. 
Moreover, MEFs deficent in the Suv39h1 and Suv39h2, 
H3K9 histone methyltransferases, have abnormally long 
telomeres, in agreement with the hypothesis that 
chromatin structure contributes to the regulation of 
telomere length [72]. In the telomerase deficient mouse, 
critically short telomeres are characterized by the loss of 
heterochromatin marks at subtelomeric regions 
including DNA methylation, H3K9 and H4K20 
trimethylation and histone hypoacetylation [75]. 
Therefore, the interplay between chromatin 
modifications and telomere length appears to be 
complex and remains to be fully investigated. 
 
  Recent studies in human cells have directly linked 
chromatin modifications to cellular senescence. Human 
primary fibroblasts, in which levels of the H3K9 
deacetylase SIRT6 are experimentally decreased, 
undergo premature cellular senescence [47]. These cells 
exhibit telomere dysfunction and chromosomal end-to-
end to fusions, specifically linked to alteration of SIRT6 
enzymatic activity. SIRT6 knockdown human fibroblasts 
and SIRT6 deficient mouse cells show H3K9 
hyperacetylation at telomeric loci, thereby, demon-
strating SIRT6 H3K9 deacetylase targets telomeres [47]. 
This study demonstrates that telomere length and 
function require epigenetic modifications and alterations 
to these regulatory mechanisms lead to telomeric 




As organisms age, changes occur at many levels, 
including transcriptional regulation and nuclear 
architecture. While it becomes clear that modulation of 
the chromatin structure influences molecular events at 
the nexus of cellular aging, several questions remain: 
First, are specific chromatin modifications a cause or a 
consequence of cellular senescence? As presented 
above, loss-of-function experiments have begun to shed 
light on the direct contribution of specific modifiers to 
cellular aging. Second, if chromatin modifiers can 
directly contribute to the aging phenotype, what is the 
molecular circuitry leading to the modulation of their 
activities during the aging process, and may it be altered 
as a therapeutic means? Finally, one of the biggest 
challenges in the understanding of the aging process is 
to decipher the connections between the seemingly 
independent molecular events that have been reported in 
different settings of senescence. The recent develop-
ment of small molecules that interfere with specific 
histone modifiers and their use in clinical trials, should 
provide new opportunities for the therapeutic 
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